Corporate Finance
Dedicated, independent, specialist service
Corporate Finance
Our Corporate Finance and Equity Capital Markets teams focus on four core sectors: life sciences & healthcare, European real estate, tech & fintech and infrastructure & renewables. Within these sectors, we’re not only intrinsically familiar with the companies and investors; we’re also up-to-date on the latest developments and trends. We generate insights that enable us to provide our clients with invaluable support when it comes to mergers & acquisitions, IPOs, equity capital markets and debt advisory services. Thanks to our independent advice and dedication to achieving results that exceed expectations, clients come back to us time and again.
1.
Unique sector knowledge and expertise
With our internationally operating sector teams and a global investor base, we have long-standing transaction experience in M&A, equity capital markets and debt advisory.2.
Transparent and independent advice
We build long-term client relationships, and run a straightforward product offering focusing uniquely on the needs of our clients.3.
Long-term view with results-driven approach
With good independent advice comes repeat business and long-term growth. Our results driven approach will help achieve high deal certainty for our clients.
Products and services
Benefit from our specialist sector knowledge with solutions tailored exclusively to corporate finance.
Mergers & acquisitions
For both listed and private companies, with extensive experience in sell-side and buy-side.
Private placements
For companies looking to access our global investor network for equity capital in a non-listed setting.
Active in the following sectors
Transactions
Great cooperation makes for excellent transactions. Our outstanding sector knowledge combined with a strong focus on understanding stocks and companies ensures we have a superior industry network and distribution power, leading to a successful track record in the market.
We could not have done this transaction, nor reached such an outcome, without the support of Van Lanschot Kempen. Their assistance in preparing and executing the transaction, as well as generating a significant amount of interest from their network, ensured a speedy and well-structured process with a very satisfactory outcome.
Curious to know more?
Jan de Kerpel
Managing Director Life Sciences and Healthcare
Thomas ten Hoedt
Managing Director European Real Estate